DNA X, Inc. (SONM)
NASDAQ: SONM · Real-Time Price · USD
3.250
+0.140 (4.50%)
At close: Jul 30, 2026, 4:00 PM EDT
3.260
+0.010 (0.31%)
After-hours: Jul 30, 2026, 4:53 PM EDT
DNA X Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.2 | 1.3 | 5.34 | 9.4 | 13.21 | 11.23 |
Cash & Short-Term Investments | 1.2 | 1.3 | 5.34 | 9.4 | 13.21 | 11.23 |
Cash Growth | -43.50% | -75.61% | -43.14% | -28.88% | 17.63% | -49.27% |
Accounts Receivable | - | - | - | 25.3 | 22.43 | 10.8 |
Other Receivables | 1.5 | - | - | 0.96 | 2.27 | 2.26 |
Total Trade Receivables | 1.5 | - | - | 26.27 | 24.7 | 13.06 |
Inventory | - | - | - | 6.52 | 3.91 | 5.54 |
Other Current Assets | 0.61 | 27.61 | 26.82 | 1.61 | 1.81 | 5.85 |
Total Current Assets | 3.3 | 28.91 | 32.17 | 43.79 | 43.63 | 35.69 |
Net Property, Plant & Equipment | - | - | - | 0.07 | 0.23 | 0.53 |
Long-Term Investments | 1.29 | 1.24 | - | - | - | - |
Other Long-Term Assets | 0.25 | 13.75 | 7.57 | 12.19 | 9.82 | 4.87 |
Total Assets | 4.84 | 43.9 | 39.74 | 56.04 | 53.69 | 41.09 |
Accounts Payable | 0.72 | 4.03 | 0.74 | 19.85 | 21.13 | 9.47 |
Accrued Expenses | 1.58 | 0.7 | 0.25 | 12.3 | 10.69 | 11.35 |
Current Portion of Long-Term Debt | - | - | - | - | 0.15 | 0.15 |
Current Portion of Leases | - | - | - | - | 0.07 | - |
Unearned Revenue | - | - | - | - | 0.03 | 0.01 |
Other Current Liabilities | - | 38.06 | 42.75 | - | - | - |
Total Current Liabilities | 2.3 | 48.03 | 43.74 | 32.15 | 32.06 | 20.99 |
Long-Term Debt | 1.07 | 5.07 | - | - | - | 0.07 |
Other Long-Term Liabilities | 1.55 | 2.77 | 1.7 | 1.53 | 1.58 | 1.41 |
Total Long-Term Liabilities | 2.63 | 7.83 | 1.7 | 1.53 | 1.58 | 1.48 |
Total Liabilities | 4.92 | 50.63 | 45.44 | 33.68 | 33.64 | 22.46 |
Common Stock | 0 | 0 | - | 0 | 0 | 0.02 |
Additional Paid-in Capital | 296.61 | 296.31 | 277.91 | 272.32 | 269.87 | 253.42 |
Retained Earnings | -297.6 | -304.27 | -283.61 | -249.96 | -249.87 | -234.81 |
Total Common Shareholders' Equity | -0.98 | -7.96 | -5.7 | 22.37 | 20.05 | 18.63 |
Minority Interest | 0.9 | 1.23 | - | - | - | - |
Shareholders' Equity | -0.08 | -6.73 | -5.7 | 22.37 | 20.05 | 18.63 |
Total Liabilities & Equity | 4.84 | 43.9 | 39.74 | 56.04 | 53.69 | 41.09 |
Total Debt | 1.07 | 5.07 | 0 | 0 | 0.21 | 0.21 |
Net Cash (Debt) | 0.12 | -3.76 | 5.34 | 9.4 | 13 | 11.02 |
Net Cash Growth | - | - | -43.14% | -27.71% | 17.98% | -49.41% |
Net Cash Per Share | 0.13 | -5.21 | 20.38 | 39.45 | 81.00 | - |
Book Value | -0.98 | -7.96 | -5.7 | 22.37 | 20.05 | 18.63 |
Book Value Per Share | -1.03 | -11.01 | -21.75 | 93.90 | 124.89 | - |
Tangible Book Value | -0.98 | -7.96 | -5.7 | 22.37 | 20.05 | 18.63 |
Tangible Book Value Per Share | -1.03 | -11.01 | -21.75 | 93.90 | 124.89 | - |